Under the leadership of Richard Saynor, the Sandoz Executive Committee (SEC) is responsible for overseeing the business operations of Sandoz. The SEC is made up of a diverse team of leaders with extensive experience in the generic pharmaceutical and biopharmaceutical industry. Each member of the SEC represents a specific region, business unit or global function. They share a commitment to helping people around the world access high-quality medicine.

Richard Saynor
Chief Executive Officer of Sandoz
Richard Saynor
Francisco Ballester
Head of International Region
Francisco Ballester
Martin Bischof
Head of Ethics, Risk and Compliance
Martin Bischof
Colin Bond
Chief Financial Officer
Colin Bond
Pierre Bourdage
Chief Operating Officer
Pierre Bourdage
Valerie Chew
Chief Digital Officer
Valerie Chew
claire d abreu hayling bio_0
Chief Scientific Officer
Claire D’Abreu Hayling
Glenn A. Gerecke, PhD
Global Head Sandoz Technical Operations
Glenn A. Gerecke, PhD
Rebecca Guntern
Head of Region Europe
Rebecca Guntern
Keren Haruvi
President of Sandoz US and Head of North America
Keren Haruvi
Tripti Jha - Chief People Officer Designate Sandoz
Chief People Officer Designate Sandoz
Tripti Jha
Steffen Kurzawa
Chief Communications Officer
Steffen Kurzawa
Ingrid Sollerer
General Counsel & Global Head of Legal
Ingrid Sollerer